Key Market Insights

• Presently, over 90 non-viral drug delivery systems developers are engaged in the healthcare market, located across the globe
• Currently, more than 95 non-viral drug delivery systems are offered by several players in the healthcare domain
• The partnership activity for non-viral drug delivery systems in the healthcare domain has grown at a CAGR of over 40%, in the past three years, 2018-2021
• The projected future opportunity for companies engaged in this field is expected to be well distributed across type of molecule, type of biologic delivered, type of technology, target therapeutic area, type of payment model and key geographical regions.

Table of Contents

1. PREFACE

1.1.                  Scope of the Report

1.2.                  Research Methodology

1.3.                  Market Segmentations

1.4.                  Key Questions Answered

1.5.                  Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.                  Chapter Overview

3.2.                  Need for Targeted Drug Delivery

3.3.                  Advanced Approaches for Delivery of Drug Payloads

3.4.                  Future Perspectives

4. MARKET LANDSCAPE

4.1.                  Chapter Overview

4.2.                  Intracellular Drug Delivery: List of Technologies

4.3.                  Intracellular Drug Delivery: List of Technology Developers

5. KEY INSIGHTS

5.1.                  Chapter Overview

5.2.                  Analysis by Type of Technology

5.3.                  Analysis by Company Size and Type of Molecule Delivered

5.4.                  Analysis by Location of Headquarters (Region-wise) and Type of Service Provider

5.5.                  Analysis by Company Size and Location of Headquarters

6. COMPANY COMPETITIVENESS ANALYSIS

6.1.                  Chapter Overview

6.2.                  Assumptions / Key Parameters

6.3.                  Methodology

6.4.                  Company Competitiveness Analysis: Benchmarking of Portfolio Strength

6.5.                  Company Competitiveness Analysis: Benchmarking of Partnership Strength

7. COMPANY PROFILES

7.1.                  Arcturus Therapeutics

7.2.                  Bio-Path

7.3.                  CureVac

7.4.                  Entos Pharmaceuticals

7.5.                  eTheRNA immunotherapies

7.6.                  Matinas BioPharma

7.7.                  MDimune

7.8.                  PCI Biotech

8. PATENT ANALYSIS

8.1.                  Chapter Overview

8.2.                  Scope and Methodology

8.3.                  Intracellular Drug Delivery Technologies: Patent Analysis

8.4.                  Intracellular Drug Delivery Technologies: Patent Valuation Analysis

9. PARTNERSHIPS AND COLLABORATIONS

9.1.                  Chapter Overview

9.2.                  Partnership Models

9.3.                  Intracellular Drug Delivery Technologies: List of Partnerships and Collaborations

10. OPPORTUNITY ASSESSMENT FRAMEWORK: KALBACH INNOVATION MODEL, COMPETITVE ASSESSMENT FRAMEWORK AND BCG MATRIX

10.1.                Chapter Overview

10.2.                Kalbach Innovation Model

10.3.                Competitive Assessment Framework

10.4.                BCG Matrix

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

11.1.                Chapter Overview

11.2.                Key Assumptions

11.3.                Forecast Methodology

11.4.                Global Non-Viral Intracellular Drug Delivery Technologies Market, 2022-2035

11.5.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Payment Model Employed, 2022 and 2035

11.6.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Molecule Delivered, 2022 and 2035

11.7.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Biologic Delivered, 2022 and 2035

11.8.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Technology, 2022 and 2035

11.9.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Target Therapeutic Areas, 2022 and 2035

11.10.              Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Geography, 2022 and 2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

News article

Modular Facility Manufacturers Market

Learn from experts:  do you know about these emerging industry trends?

Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com